General Stability | Organism |
---|---|
activity is stabilized by acetylation | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
bempedoic acid | - |
Homo sapiens | |
Hydroxycitrate | - |
Homo sapiens |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
480000 | - |
- |
Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + citrate + CoA | Homo sapiens | - |
ADP + phosphate + acetyl-CoA + oxaloacetate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P53396 | - |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
acetylation | the enzyme is activated by acetylation at lysine residues 540, 546, and 554 | Homo sapiens |
phosphoprotein | the enzyme is activated by phosphorylation | Homo sapiens |
ubiquitination | the enzyme is degraded by ubiquitinylation | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + citrate + CoA | - |
Homo sapiens | ADP + phosphate + acetyl-CoA + oxaloacetate | - |
? |
Subunits | Comment | Organism |
---|---|---|
tetramer | the tetramer comprises four identical subunits, each resulting from the fusion of N-terminal citryl-CoA synthetase module and the catalytic C-terminal citryl-CoA lyase domain | Homo sapiens |
Synonyms | Comment | Organism |
---|---|---|
ACLY | - |
Homo sapiens |
ATP citrate lyase | - |
Homo sapiens |
Organism | Comment | Expression |
---|---|---|
Homo sapiens | overexpressed in many cancers. ACLY transcription is promoted by SREBP1 | up |
General Information | Comment | Organism |
---|---|---|
metabolism | the enzyme links energy metabolism provided by catabolic pathways to biosynthesis. ACLY plays a pivotal role in cancer metabolism through the potential deprivation of cytosolic citrate, a process promoting glycolysis through the enhancement of the activities of PFK 1 and 2 with concomitant activation of oncogenic drivers such as PI3K/AKT which activate ACLY and the Warburg effect in a feed-back loop | Homo sapiens |